Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback